| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |